Bicycle Therapeutics
Bicycle Therapeutics, a pioneering biotechnology company headquartered in Cambridge, GB, is at the forefront of developing innovative therapies using its proprietary Bicycle platform. Founded in 2009, the company focuses on creating a new class of medicines known as Bicycles, which are designed to target and treat a range of diseases, including cancer and autoimmune disorders. With a strong emphasis on precision medicine, Bicycle Therapeutics has achieved significant milestones, including strategic partnerships and advancing multiple candidates into clinical trials. Their unique approach combines the benefits of small molecules and biologics, positioning them as a leader in the biopharmaceutical industry. As they continue to expand their operational reach, Bicycle Therapeutics remains committed to transforming patient outcomes through cutting-edge therapeutic solutions.
DitchCarbon Score
How does Bicycle Therapeutics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bicycle Therapeutics's score of 3 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bicycle Therapeutics's reported carbon emissions
Bicycle Therapeutics, headquartered in Great Britain, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of concrete emissions data, it is essential to note that many companies in the biotechnology sector are increasingly focusing on sustainability and climate commitments. This trend often includes setting science-based targets for emissions reductions and engaging in initiatives aimed at minimising their environmental impact. However, without specific information from Bicycle Therapeutics, it is unclear what their particular commitments or strategies may entail.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bicycle Therapeutics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
